1. Opioid use disorder: treatment with injectable and implantable buprenorphine : report to Congressional committees Publication: Washington, DC : United States Government Accountability Office, August 2020 Subject(s): Buprenorphine -- therapeutic useGovernment RegulationOpiate Substitution TreatmentOpioid-Related Disorders -- therapySubstance Withdrawal Syndrome -- therapyUnited States
